SETDB2-CAB39L Fusion FISH Probe
The SETDB2-CAB39L Fusion FISH Probe is used to confirm a fusion of the SETDB2 and CAB39L genes. The fusion of the SETDB2 and CAB39L genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SETDB2-CAB39L-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SETDB2-CAB39L-20-AQAQ | 20 (40 μL) | 200 μL |
|
CAB39L Gene Summary
The Calcium Binding Protein 39 Like (CAB39L) gene is located on chr13 :49882785-50018221 at 13q14.2.
Gene Name: Calcium Binding Protein 39 Like
Chromosome: CHR13: 49882785 -50018221
Locus: 13q14.2
SETDB2 Gene Summary
This gene encodes a member of a family of proteins that contain a methyl-CpG-binding domain (MBD) and a SET domain and function as histone methyltransferases. This protein is recruited to heterochromatin and plays a role in the regulation of chromosome segregation. This region is commonly deleted in chronic lymphocytic leukemia. Naturally-occuring readthrough transcription occurs from this gene to the downstream PHF11 (PHD finger protein 11) gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Gene Name: SET Domain Bifurcated 2
Chromosome: CHR13: 50018428 -50069139
Locus: 13q14.2
Gene Diseases
The SETDB2 CAB39L Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|